Значения термина poor responder на английском

Patients were classified as good responder and poor responder according to therapeutic responsiveness on KD.

The defects in resistance observed in genetically poor responder mice and in mice treated with silica appear to involve the first step in recognition.

Salvage of poor responders by alternative postsurgical chemotherapy was unsuccessful.

Functional parameters were not predictive of outcome of treatment; the poor responders showed major psychological problems.

However, neither are satisfactory to identify poor responders.

Six patients rebled on follow-up between the studies, all of them were poor responders to intravenous propranolol.

However, reductions in SMA and FA flow velocity were significantly greater in good responders than in poor responders.

Patients with a good pathological response to treatment had gene patterns that clustered distinctly from those of poor responders.

Data are lacking on the eventual outcomes of individuals who are partial responders or poor responders to initial treatment.

Despite previous attempts to improve the outcome of poor responders by modifying the postoperative chemotherapy, their prognosis remains poor.

We hypothesized that plasma proteomic profiles could be used to distinguish good from poor responders prior to the start of treatment.

If DBS stimulates and does not inactivate STN projection neurons, flow reduction in the poor responders may be secondary to increased inhibitory basal ganglia output.